Practical: Oncology Flashcards
A carcinoma is, by defintion, a malignant tumor derived from
a. ectodermal cells
b. surface tissue
c. epithelium
d. parenchyme
c. epithelium
Whichc tumor differentiates towards mesenchymal tissues?
a. carcinoma
b. lymphoma
c. sarcoma
d. deminoma
c. sarcoma
Which microscopic abnormality is an important potential carcinoma precursor?
a. dysplasia of the epithelium
b. introduction of cytogenic stroma
c. metaplasia of the epithelium
d. loss of epithelial surface tissue
a. dysplasia of the epithelium
The term ‘dysplasia, referring to epithelial abnormalities’, means:
a. the presence of atypical mitoses, as a sign of malignancy
b. early genetic damage that does not result in morphologic deviations yet
c. loss of organized epithelial maturation, combined with invasive growth
d. loss of organized epithelial maturation, with deviations in nucleus size and shape
d. loss of organized epithelial maturation, with deviations in nucleus size and shape
Tumour grade as defined by a pathologist is a parameter of:
a. the extensiveness of the tumour
b. tumour aggressiveness
c. presence or absence of metastases
d. presence or absence of invasive growth
b. tumour aggressiveness
Clonality (=monoclonality) of a tumor refers to the fact that all tumour cells…
a. descend from a single cells
b. are genetically identical
c. are morphologically identical
d. contain the same combination of mutations
a. descend from a single cells
tumour is (mono-)clonal, which means that it originates from a single transformed call. an inscreasing number of variants is formed within one tumour by genetic instability
What is meant by ‘pleomorphism’ of tumour cells in oncology?
a. variation in tumour cell differentiation type
b. differences between cells of the primary tumour and cells from metastases
c. the frequent occurrence of mitosis figures
d. variation in growth and shape of tumour cells and their nuclei
d. variation in growth and shape of tumour cells and their nuclei
pleoforfe tumorcellen (melanoom)
Which growth property is defining for a malignant tumour (instead of a benign tumour)?
a. Expansive growth, with formation of a centre that compresses surrounding tissues
b. significant growth, causing the tumour to reach a size of more than 10 centimeters
c. invasion of surrounding tissues, causing destruction of said tissue
d. net tumour growth (more cell division than cell loss)
c. invasion of surrounding tissues, causing destruction of said tissue
Tumour STAGE refers to…
a. the extent to which the tumour has spread throughout the body and metastasized.
b. The phase of tumour progression towards the ending stage of an aggressive, anaplastic tumour
c. The general state of the patient, in which the general condition and local problems caused by the tumours are taken into account
d. Tumour aggressiveness and susceptiblity to therapy
a. the extent to which the tumour has spread throughout the body and metastasized.
What is meant by ‘differentiation’ in the context of tumour cells?
a. hormone production by a tumor
b. antibody production by a tumour
c. morphologic and function similarity of neoplastic cells to a (normal) cell type
d. genetic similarity of neoplastic cells to a (normal) cell type
c. morphologic and function similarity of neoplastic cells to a (normal) cell type
What is the correct term for the characteristic increase in dark staining of tumour cell nuclei?
a. anisokaryosis
b. polymorphism
c. hyperchromasia
d. metaplaia
c. hyperchromasia
“Double minutes” and “HSRs” (homogeneously staining regions) are distinctive for
a. amplifications
b. deletions
c. translocations
d. inversions
a. amplifications
What is meant by the growth fraction of a tumour?
a. all tumour cells are in the S- and M-phase of cell cycle
b. the average duration of the cells cycle in tumour cells, as a percentage of the cell cycle duration in corresponding normal tissues
c. the fraction of tumour cells that partakes in tumour proliferation
d. the tumour doubling time divided the tumour volume
c. the fraction of tumour cells that partakes in tumour proliferation
The tumour suppressor gene p53 encodes a protein that reduces the hazard of cancer in different ways. In which way precisely (1/more alternative)
a. induction of apoptosis, blockage of telomerase
b. induction DNA repair blockage of MHC class expression, induction of heterochromatin
c. induction of cell cycle arrest, induction of DNA repair, induction of apoptosis
d. induction of heterochromatin, induction of cell cycle arrest
c. induction of cell cycle arrest, induction of DNA repair, induction of apoptosis
What is LOW?
a. low output heterochromatin
b. linkage of hierarchy
c. low-grade oncogenic hyperplasia
d. loss of heterozygosity
d. loss of heterozygosity
Examples of substances that play a role in chemical carcinogenesis are ‘initiators’ and ‘promotors’
a. they are mutagenic and do not stimulate proliferation
b. they are not mutagenic but they do stimulate proliferation
c. they are mutagenic and stimulate proliferation
d. they are not mutagenic and do not stimulate proliferation
b. they are not mutagenic but they do stimulate proliferation
How would you describe the loss of differentiation in a malignant tumour?
a. clonality
b. mull phenotype
c. amorphy
d. anaplasia
d. anaplasia
An oncogenic mutation in as RAS gene leads to an increased activity of the RAS protein. What causes this increase in activity?
a. RAS protein is more abundant as a consequence of the amplification of the RAS gene
b. The RAS protein is always active as a consequence of point mutation in the RAS gene
c. Alternative splicing of RAS mRNA results in accumulation of RAS protein, because degradation of RAS in proteasome is inhibited
d. The Ras protein is targeted towards the cell nucleus because of a change in the signal peptide
b. they are not mutagenic but they do stimulate proliferation
An activating (gain of function) mutation in a certain gene contributes to the onset of cancer. to which gene group does this gene belong
a. proto-oncogens
b. tumour suprresor genes
c. genes that encode apoptosis-enhancing proteins
d. genes that encode DNA-repair or enzymes
a. proto-oncogens
Translocations play a rol in the onset of some hematologic malignancies. Which oncogenes are activated by such a translocation?
a. RAS and BRAF
b. ERB-B2 and RB
c. C-MYC and CL-2
d. EGFR and APC
c. C-MYC and CL-2
Invasive growth of malignant tumors required degradation of the extracellular matrix. Which enzymes are directly responsible for this process?
a. matrix metalloproteinases (MMPs)
b. ubiquitinases
c. the family of “scatter factors”
d. prostaglandins
a. matrix metalloproteinases (MMPs)